ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
OS Therapies Incorporated

OS Therapies Incorporated (OSTX)

2.23
0.24
(12.06%)
Closed 15 February 8:00AM
2.06
-0.17
( -7.62% )
Pre Market: 9:32PM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
2.06
Bid
-
Offer
-
Volume
16,799
0.00 Day's Range 0.00
1.58 52 Week Range 7.00
Market Cap
Previous Close
2.23
Open
-
Last Trade Time
21:32:10
Financial Volume
-
VWAP
-
Average Volume (3m)
1,280,437
Shares Outstanding
21,238,378
Dividend Yield
-
PE Ratio
0.00
Earnings Per Share (EPS)
-
Revenue
-
Net Profit
-6.38M

About OS Therapies Incorporated

OS Therapies (OST) is a clinical stage therapeutic company focused on the identification, development and commercialization of treatments for Osteosarcoma (OS) and other solid tumors. OS Therapies was launched to meet significant unmet need for new treatments in cancers of the bone in kids and adult... OS Therapies (OST) is a clinical stage therapeutic company focused on the identification, development and commercialization of treatments for Osteosarcoma (OS) and other solid tumors. OS Therapies was launched to meet significant unmet need for new treatments in cancers of the bone in kids and adults. Osteosarcoma is an extremely challenging and often aggressive cancer that has particular treatment challenges due to location, changing genotypes, and high recurrence rates. At OST, we are trying to answer the calls for new treatments, considering there have been no new treatments for OS in over 30 years. OST has expanded the pipeline beyond Osteosarcoma with OST-HER2 into other solid tumors with the same recurrence mechanism of action, including Breast, Esophageal and Lung cancer. With the addition of OST-tADC, considered a next generation Antibody Drug Conjugate (ADC) platform technology, we will be targeting Ovarian, Lung and Pancreatic cancer. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Middletown, Delaware, USA
Founded
-
OS Therapies Incorporated is listed in the Pharmaceutical Preparations sector of the American Stock Exchange with ticker OSTX. The last closing price for OS Therapies was US$2.23. Over the last year, OS Therapies shares have traded in a share price range of US$ 1.58 to US$ 7.00.

OS Therapies currently has 21,238,378 shares in issue. The market capitalisation of OS Therapies is US$47.36 million.

OSTX Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.210.7526881721.862.981.8197157662.22720989CS
4-1.14-35.6253.23.531.7124233852.2342679CS
120.041.98019801982.0271.7112804372.94316105CS
26-1.45-41.31054131053.5171.585790172.96275594CS
52-1.94-48.5471.585826423.04340507CS
156-1.94-48.5471.585826423.04340507CS
260-1.94-48.5471.585826423.04340507CS

OSTX - Frequently Asked Questions (FAQ)

What is the current OS Therapies share price?
The current share price of OS Therapies is US$ 2.06
How many OS Therapies shares are in issue?
OS Therapies has 21,238,378 shares in issue
What is the market cap of OS Therapies?
The market capitalisation of OS Therapies is USD 47.36M
What is the 1 year trading range for OS Therapies share price?
OS Therapies has traded in the range of US$ 1.58 to US$ 7.00 during the past year
What is the reporting currency for OS Therapies?
OS Therapies reports financial results in USD
What is the latest annual profit for OS Therapies?
The latest annual profit of OS Therapies is USD -6.38M
What is the registered address of OS Therapies?
The registered address for OS Therapies is 18 MANASSAS DRIVE, MIDDLETOWN, DELAWARE, 197093802
What is the OS Therapies website address?
The website address for OS Therapies is www.ostherapies.com
Which industry sector does OS Therapies operate in?
OS Therapies operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
GENCGencor Industries Inc
US$ 16.00
(20.12%)
10
ROLRHigh Roller Technologies Inc
US$ 4.83
(19.55%)
7
BGIBirks Group Inc
US$ 1.38
(14.05%)
629
ECFEllsworth Growth and Income Fund Ltd
US$ 11.37
(13.25%)
2
COE51Talk Online Education Group
US$ 23.99
(13.16%)
2
XDECFT Vest US Equity Enhance & Moderate Buffer ETF December
US$ 31.00
(-18.36%)
1
EFSH1847 Holdings LLC
US$ 0.1546
(-11.15%)
39.7k
KAPAKairos Pharma Ltd
US$ 1.23
(-10.22%)
2.93k
LODEComstock Inc
US$ 0.3182
(-9.47%)
93.96k
SOARVolato Group Inc
US$ 0.17
(-9.43%)
11.66k
ETHU2x Ether ETF
US$ 4.40
(-2.65%)
1.32M
TSLZT Rex 2X Inverse Tesla Daily Target ETF
US$ 2.81
(-1.92%)
726.56k
SOXLDirexion Daily Semiconductor Bull 3X Shares
US$ 29.12
(2.00%)
647.3k
YINNDirexion Daily FTSE China Bull 3X Shares
US$ 42.67
(4.51%)
478.63k
FXIiShares China Large Cap
US$ 35.59
(1.57%)
459.38k

OSTX Discussion

View Posts
JPetroInc JPetroInc 2 days ago
too much debt AND the CBO is a lying POS shyster who destroys SH value



C-Suites my royal right butt cheek ...!

just look at what Gerald Commissiong did to AMBS and TOMDF

drove both into insolvency and stole everything he could via serial dilution from his SH's

its just that plain and simple...!



Gerald Commissiong - WAPOS
👍️0
tw0122 tw0122 2 days ago
Yes only played premarket to much debt here 
👍️0
Monksdream Monksdream 3 days ago
OSTX under $3
👍️0
JPetroInc JPetroInc 4 days ago
don't touch it...

unless you're Jack be nimble Jack be quick...

AJMHO
👍️0
tedpeele tedpeele 4 days ago
I'm seeing 1.6m float
👍️0
glenn1919 glenn1919 4 days ago
OSTX...................................................newone.....................................https://stockcharts.com/h-sc/ui?s=ostxp=W&yr=1&mn=3&dy=0&id=p96837884856
👍️0
tw0122 tw0122 4 days ago
$4.10 + 104% went to $5s last run January but profit taking hitting bigger now 
👍️0
JPetroInc JPetroInc 4 days ago
I wouldn't touch ANYTHING Gerald Commissiong is involved with...

did you see the last P&D they pulled in Dec., 24

AJMHO
👍️0
tw0122 tw0122 4 days ago
$3.36 + 70% Guess will find out later flip out time ..
 The Company anticipates submitting a Biologics Licensing Application (BLA) to the US FDA for OST-HER2 in osteosarcoma in 2025 and, if approved, would become eligible to receive a Priority Review Voucher that it could then sell. OST-HER2 has completed a Phase 1 clinical study primarily in breast cancer patients, in addition to showing preclinical efficacy data in various models of breast cancer. OST-HER2 has been conditionally approved by the U.S. Department of Agriculture for the treatment of canines with osteosarcoma.

👍️0
JPetroInc JPetroInc 4 days ago
interesting - wonder where they'll get their funding

and if it will be toxic - Gerald...?
👍️0
tw0122 tw0122 4 days ago
OSTK 3.06 + 52% 
👍️0
tw0122 tw0122 4 days ago
OSTX $2.30 + 15% .. NEW YORK--(BUSINESS WIRE)--Feb. 14, 2025--OS Therapies, Inc. (NYSE-A: OSTX), a clinical-stage biotechnology company advancing immunotherapies and targeted drug conjugates for cancer treatment, today announced that it has entered into agreements for the commercial manufacture of OST-HER2. 
👍️0
tw0122 tw0122 1 month ago
Didn't trade it but see you under $4 maybe lol thanks
👍️0
TheFinalCD TheFinalCD 1 month ago
https://x.com/brentkhack_TX/status/1879510244243783831
👍️0
tw0122 tw0122 1 month ago
Lung action $8s + 92% 17m floater 
👍️0
JPetroInc JPetroInc 5 months ago
looking good Gerald...!

IMHO, you'll have this trading at $0.00028 in record time



here comes the Astoria Queens financial mafia wrecking crew to help assist you in your next financial debacle

so much for running TOMDF into insolvency and jumping ship to this firm which didn't last long:

Fortitude Advisors LLC

https://fortitudeadvisors.com/team/

"He is also the Chief Business Officer at OS Therapies, Inc. starting in 2024 and the Managing Partner at Fortitude Advisors LLC since 2019."

https://uk.marketscreener.com/insider/GERALD-COMMISSIONG-A19LFK/

I give Gerald Commissiong 6 months before OSTX fire's his arse - and for good measure...!

MOO pathetic
👍️0
JPetroInc JPetroInc 5 months ago
uh ho - Gerald Commissiong OSTX's new Chief Business Officer executive named...

and is the same old same old serial dilution 'scam artist' from AMBS & TOMDF

here we go again folks...!



buyers be ware - check these other 2 tickers for the catastrophic results by this Stanford Univ. Financial Engineering hack

https://ostherapies.com/leadership/

SMH - can't make this stuff up - sad but true...!

MOO tool
👍️0

Your Recent History

Delayed Upgrade Clock